The function and molecular mechanism of HIF-1α interacted with p-STAT3 in promoting G6PD overexpression in chronic myelogenous leukemia cells
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Yueli Ni und 16 weiteren Autor:innen. Beteiligte Einrichtung: Tumor Prevention, Treatment and Translational Research Center, School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, China; …. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Hypoxia-Inducible Factor 1, alpha Subunit, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Glucosephosphate Dehydrogenase. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Chronic myeloid leukemia (CML) is a malignant myeloproliferative neoplasm originating from hematopoietic stem cells, which substantially contributes to the morbidity and mortality among leukemia patients. Our findings demonstrated that glucose-6-phosphate dehydrogenase (G6PD) is aberrantly overexpressed in CML, where it promotes the proliferation of CML cells and modulates their cell cycle distribution. Furthermore, we observed a positive correlation between G6PD overexpression and the resistance of CML cells to imatinib. Subsequent mechanistic investigations revealed that the complex formed by the interaction of phosphorylated STAT3 (p-STAT3) and hypoxia-inducible factor 1α (HIF-1α) functions as a novel transcriptional regulator of G6PD, thereby driving its increased expression. Collectively, this study provides compelling evidence that strategies directly targeting p-STAT3/HIF-1α-G6PD may represent an effective therapeutic approach to suppress CML cells proliferation and overcome drug resistance, offering new insights into the diagnosis and clinical management of CML patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tumor Prevention, Treatment and Translational Research Center, School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, China; Department of Biochemistry and Molecular Biology, School of Basic Medi…
- Department of Blood Screening Laboratory, Yunnan Kunming Blood Center, China.
- Tumor Prevention, Treatment and Translational Research Center, School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, China; Departments of Pathology, The First Affiliated Hospital of Kunming Med…
Zitieren
APA
Ni, Y., Wang, L., Li, Y., Duan, Y., Shao, H., Dong, Y., Zhang, J., Xu, Z., Yuan, L., Dou, Y., Bai, Z., Cui, K., Teng, Z., Shahzad, A., Liu, W., Yang, Z., & Zhang, Q. (2026). The function and molecular mechanism of HIF-1α interacted with p-STAT3 in promoting G6PD overexpression in chronic myelogenous leukemia cells. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112451
Vancouver
Ni Y, Wang L, Li Y, Duan Y, Shao H, Dong Y, et al. The function and molecular mechanism of HIF-1α interacted with p-STAT3 in promoting G6PD overexpression in chronic myelogenous leukemia cells. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112451
BibTeX
@article{Ni2026,
author = {Ni, Yueli and Wang, Lifeng and Li, Yongping and Duan, Youbin and Shao, Hanyue and Dong, Yurong and Zhang, Jinshan and Xu, Zhe and Yuan, Lu and Dou, Yu and Bai, Ziyuan and Cui, Kun and Teng, Zhuoran and Shahzad, Asif and Liu, Wenjing and Yang, Zhe and Zhang, Qiao},
title = {The function and molecular mechanism of HIF-1α interacted with p-STAT3 in promoting G6PD overexpression in chronic myelogenous leukemia cells},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112451}
}
EUVIMED